natgillin/translations-raw huggingface dataset:
The dose of PegIntron for monotherapy should be reduced in patients with moderate or severe renal impairment (see sections 4.2 and 4.4).
Bolesnicima s umjerenim ili teškim oštećenjem funkcije bubrega treba smanjiti dozu lijeka PegIntron u monoterapiji (vidjeti dijelove 4.2 i 4.4).
Predictability of sustained virological response - Naïve patients: Virological response by week 12 is defined as at least 2-log viral load decrease or undetectable levels of HCV-RNA.
Predvidljivost trajnog virološkog odgovora - bolesnici koji prethodno nisu bili liječeni: Virološki odgovor do 12. tjedna definira se kao smanjenje količine virusa za najmanje 2 log ili kao nemjerljiva HCV-RNK.
PegIntron is available in different pack sizes: - 1 vial of powder for solution for injection and 1 ampoule of solvent for injection; - 1 vial of powder for solution for injection, 1 ampoule of solvent for injection, 1 injection syringe,
PegIntron je dostupan u pakiranjima koja sadrže: - 1 bočicu s praškom za otopinu za injekciju i 1 ampulu s otapalom za parenteralnu primjenu; - 1 bočicu s praškom za otopinu za injekciju, 1 ampulu s otapalom za parenteralnu primjenu,
The following instructions explain how to inject this medicine yourself.
Sljedeće upute objašnjavaju kako ćete sami sebi dati injekciju lijeka PegIntron.
Please refer to the ribavirin and boceprevir Summary of Product Characteristics (SmPCs) when PegIntron is to be used in combination with these medicines.
Molimo pročitajte Sažetak opisa svojstava lijeka za ribavirin i boceprevir ako će se PegIntron primjenjivati u kombinaciji s tim lijekovima.
Patients were randomized to receive either PegIntron (100 or 150 µg/week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight).
Bolesnici su bili randomizirani tako da su primali PegIntron (100 ili 150 μg na tjedan ovisno o tjelesnoj težini) i ribavirin (800-1200 mg na dan ovisno o tjelesnoj težini) ili interferon alfa-2b (3 mil.
PegIntron/ribavirin retreatment of prior treatment failures In a non-comparative trial, 2,293 patients with moderate to severe fibrosis who failed previous treatment with combination alpha interferon/ribavirin were retreated with PegIntron, 1.5 micrograms/kg subcutaneously, once weekly, in combination with weight adjusted ribavirin.
U nekomparativnom ispitivanju su 2293 bolesnika s umjerenom do teškom fibrozom, u kojih prethodno liječenje interferonom alfa u kombinaciji s ribavirinom nije bilo uspješno, ponovno liječena lijekom PegIntron u supkutanoj dozi od 1,5 mikrograma/kg jedanput na tjedan u kombinaciji s ribavirinom u dozi prilagođenoj tjelesnoj težini.
A small volume is lost during preparation of PegIntron for injection when the dose is measured and injected.
Tijekom pripreme lijeka PegIntron za injekciju, pri mjerenju doze i davanju injekcije, izgubi se mali dio volumena.
The pharmacokinetics of PegIntron following a single subcutaneous dose of 1.0 microgram/kg were not affected by age.
Dob nije utjecala na farmakokinetiku lijeka PegIntron nakon jedne supkutane doze od 1,0 mikrograma/kg.
Genotype 1* By week 4*** (n=950) HCV-RNA negative
Genotip 1* Do 4. tjedna *** (n=950)
Your healthcare provider will instruct you how to self-inject this medicine.
Vaš zdravstveni radnik će Vas uputiti kako da si sami date injekciju lijeka PegIntron.
When patients are administered PegIntron with medications metabolized by CYP1A2 or CYP2D6, the extent of the decrease in cytochrome P 450 activity is unlikely to have a clinical impact, except with medicines which have a narrow therapeutic margin (Table 5).
Kada se PegIntron bolesnicima primjenjuje s lijekovima koji se metaboliziraju posredstvom CYP1A2 ili CYP2D6, razmjer smanjenja aktivnosti citokroma
Very common side effects (may affect more than 1 in 10 people): - breathing problems (including shortness of breath), - feeling depressed, - trouble sleeping, thinking or concentrating, dizziness, - severe stomach pain or cramps, - fever or chills beginning after a few weeks of treatment, - painful or inflamed muscles (sometimes severe),
Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba): - tegobe s disanjem (uključujući nedostatak zraka), - depresivnost, - poteškoće sa spavanjem, razmišljanjem ili koncentracijom, omaglica, - jaka bol ili grčevi u trbuhu, - vrućica ili zimica koje se javljaju nakon nekoliko tjedana liječenja, - bolni ili upaljeni mišići (ponekad jako).
1.0 g/kg
1 μg/kg
This medicine, when given alone, is usually given at a dose of 0.5 or 1.0 microgram per kilogram of body weight once a week, for 6 months to 1 year.
Primjena u odraslih - liječenje samo lijekom PegIntron Kad se primjenjuje samostalno, ovaj lijek se obično daje u dozi od 0,5 ili 1,0 mikrograma po kilogramu tjelesne težine jedanput na tjedan, tijekom 6 mjeseci do godinu dana.
Table 2 Monotherapy dosing 0.5 µg/kg
Tablica 2 Doziranje u monoterapiji 0,5 µg/kg
Please refer to the ribavirin SmPC when PegIntron is to be used in combination with ribavirin.
Molimo pročitajte Sažetak opisa svojstava lijeka za ribavirin ako će se PegIntron primjenjivati u kombinaciji s ribavirinom.
In a clinical trial, approximately 1.2 % of patients treated with PegIntron or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment.
U jednom su kliničkom ispitivanju prijavljeni po život opasni psihijatrijski događaji u približno 1,2% bolesnika liječenih lijekom PegIntron ili interferonom alfa-2b u kombinaciji s ribavirinom.
No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study.
U ispitivanju farmakokinetike višekratnih doza nisu zabilježene farmakokinetičke interakcije između lijeka PegIntron i ribavirina.
PegIntron is available in different pack sizes: - 1 pre-filled pen containing powder and solvent for solution for injection, 1 needle ("Push-On Needle"),
PegIntron je dostupan u pakiranjima koja sadrže: - 1 napunjenu brizgalicu (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 1 iglu (potisna igla )
Patients were randomized to receive either PegIntron (1.5 µg/kg/week) plus ribavirin (800 mg/day) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800 mg/day) for 48 weeks with a follow-up period of 6 months.
Bolesnici su bili randomizirani u skupine koje su primale PegIntron (1,5 μg/kg na tjedan) i ribavirin (800 mg na dan) ili interferon alfa-2b (3 mil.
Careful co-administration of thioridazine with the product (PegIntron) is recommended.
Preporučuje se oprez kod istodobne primjene tioridazina s ovim lijekom (PegIntron).
Discontinuation of PegIntron should be considered in patients who develop new or worsening ophthalmological disorders.
U bolesnika u kojih se razviju novi ili pogoršaju postojeći oftalmološki poremećaji treba razmotriti obustavu lijeka PegIntron.
Amount of PegIntron to administer (µg)
Količina lijeka PegIntron koju treba primijeniti (µg)
Therefore, each pre-filled pen contains an excess amount of solvent and PegIntron powder to ensure delivery of the labelled dose in 0.5 ml of PegIntron, solution for injection.
Zato svaka napunjena brizgalica sadrži nešto veću količinu otapala i PegIntron praška kako bi se osigurala primjena deklarirane doze u 0,5 ml PegIntron otopine za injekciju.
Class label for interferon products, see below Pulmonary arterial hypertension.
Značajka skupine lijekova koji sadrže interferon, vidjeti niže
Pen label - PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen
Naljepnica brizgalice - PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
Injection site reaction
Opći poremećaji i reakcije na mjestu primjene
Therefore, each vial contains an extra amount of solvent and PegIntron powder to ensure delivery of the labeled dose in 0.5 ml of PegIntron, solution for injection.
Stoga svaka bočica sadrži dodatnu količinu otapala i PegIntron praška kako bi se osigurala primjena deklarirane doze u 0,5 ml PegIntron otopine za injekciju.
nd dose reduction of PegIntron is to 0.5 µg/kg/week.
Ako je potrebno, drugo smanjenje doze lijeka PegIntron je na 0,5 μg/kg na tjedan.
Monotherapy with PegIntron and bitherapy with PegIntron and ribavirin Naïve patients
Monoterapija lijekom PegIntron i dvojna terapija lijekom PegIntron i ribavirinom Bolesnici koji prethodno nisu bili liječeni
PegIntron 120 micrograms powder and solvent for solution for injection EU/1/00/131/016
PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/016
PegIntron 1.5 micrograms/kg
PegIntron 1,5 mikrograma/kg
PegIntron 80 micrograms powder and solvent for solution for injection EU/1/00/131/006
PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/006
2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for injection; - 4 vials of powder for solution for injection, 4 ampoules of solvent for injection, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for injection; - 12 vials of powder for solution for injection, 12 ampoules of solvent for injection, 12 injection syringes, 24 injection needles and 12 cleansing swabs.
4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje; - 6 bočica s praškom za otopinu za injekciju i 6 ampula s otapalom za parenteralnu primjenu; - 12 bočica s praškom za otopinu za injekciju, 12 ampula s otapalom za parenteralnu primjenu,
PegIntron 120 micrograms - vial of powder
PegIntron 120 mikrograma - bočica s praškom
Pen label - PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen
Naljepnica brizgalice - PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
2 cleansing swabs; - 4 pre-filled pens containing powder and solvent for solution for injection, 4 needles ("Push-On Needle"),
2 tupfera za čišćenje - 4 napunjene brizgalice (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 4 igle (potisna igla)
PegIntron 150 micrograms powder and solvent for solution for injection EU/1/00/131/021
PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/021
PegIntron 80 micrograms - vial of powder
PegIntron 80 mikrograma - bočica s praškom
PegIntron 150 micrograms - vial of powder
PegIntron 150 mikrograma - bočica s praškom
- Combination of PegIntron with telbivudine.
PegIntron u kombinaciji s ribavirinom.
Package inserts of theophylline should be referred to when co-administering with the product (PegIntron)
Potrebno je pročitati uputu o lijeku za teofilin kada se primjenjuje istodobno s ovim lijekom (PegIntron).
PegIntron 50 micrograms powder and solvent for solution for injection EU/1/00/131/001
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/001
PegIntron 100 micrograms powder and solvent for solution for injection EU/1/00/131/011
PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/131/011
Detailed instructions for subcutaneous administration are provided at the end of this leaflet (see section “How to self-inject PegIntron”).
Detaljne upute za potkožnu primjenu se nalaze na kraju ove upute (vidjeti dio
PegIntron 50 micrograms - vial of powder
PegIntron 50 mikrograma - bočica s praškom
PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/035
PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/035
PegIntron 100 micrograms - vial of powder
PegIntron 100 mikrograma - bočica s praškom
PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/047
PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/047
Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving PegIntron and ribavirin combination therapy.
U bolesnika koji su primali kombiniranu terapiju lijekom PegIntron i ribavirinom prijavljene su bolesti zuba i parodonta koje mogu dovesti do gubitka zuba.
Discard the PegIntron pre-filled pen (CLEARCLICK) with any solution that is left in it after you give yourself the injection.
Nakon što si date injekciju, zbrinite PegIntron napunjenu brizgalicu (CLEARCLICK) s preostalom neupotrijebljenom otopinom.
Interferon alfa-2b (3 MIU) + ribavirin (1,000/1,200 mg)
IU) + ribavirin (1000/1200 mg)
PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/043
PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/043
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/031
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/031
PegIntron 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju peginterferon alfa-2b
Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible.
Ako primijenite više lijeka PegIntron nego što ste trebali Što prije obavijestite o tome liječnika ili drugog zdravstvenog radnika, ili liječnika odnosno drugog zdravstvenog radnika djeteta o kojem skrbite.
PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/039
PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/131/039
EU/1/00/131/011 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/012 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/131/011 (1 bočica s praškom, 1 ampula s otapalom) EU/1/00/131/012 (1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje)
PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju
EU/1/00/131/047 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/048 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/050 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/131/047 (1 brizgalica, 1 igla za injekciju i 2 tupfera za čišćenje) EU/1/00/131/048 (4 brizgalice, 4 igle za injekciju i 8 tupfera za čišćenje) EU/1/00/131/050 (12 brizgalica, 12 igala za injekciju i 24 tupfera za čišćenje)
Common side effects (may affect up to 1 in 10 people): - fungal infection, common cold, cold sores, pharyngitis (sore throat), sinusitis, ear infection, coughing, throat pain, feeling cold, eye pain, - decrease in blood clotting cells called platelets, that may result in easy bruising and spontaneous bleeding, swollen glands (swollen lymph nodes), blood thyroid tests abnormalities, decrease in thyroid gland activity, which may make you feel tired, depressed, increase your sensitivity to cold and other symptoms, - wanting or attempting to harm yourself aggressive behaviour, agitation, anger, mood changes, nervousness or restlessness, depression, feeling anxious, trouble falling asleep or staying asleep, emotional instability, poor quality sleep, feeling sleepy, disturbance in attention.
Česte nuspojave (mogu se javiti u do 1 na 10 osoba): - gljivična infekcija, obična prehlada, herpetični mjehurići, faringitis (upala grla), upala sinusa, infekcija uha, kašalj, grlobolja, osjećaj hladnoće, bol u oku, - smanjenje broja stanica koje zgrušavaju krv, a zovu se trombociti, što može dovesti do laganog nastajanja modrica i spontanog krvarenja, otečene žlijezde (otečeni limfni čvorovi), poremećaji nalaza krvnih pretraga funkcije štitnjače, smanjena aktivnost štitnjače, zbog čega se možete osjećati umorno, depresivno, biti osjetljiviji na hladnoću i imati druge simptome,
EU/1/00/131/006 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/007 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/131/006 (1 bočica s praškom, 1 ampula s otapalom) EU/1/00/131/007 (1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje)
PegIntron 120 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
EU/1/00/131/023 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/024 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
EU/1/00/131/023 (4 bočice s praškom, 4 ampule s otapalom) EU/1/00/131/024 (4 bočice s praškom, 4 ampule s otapalom, 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje)
PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 150 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 150 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 120 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 120 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
EU/1/00/131/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
EU/1/00/131/008 (4 bočice s praškom, 4 ampule s otapalom) EU/1/00/131/009 (4 bočice s praškom, 4 ampule s otapalom, 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje)
PegIntron 150 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
EU/1/00/131/016 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/017 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/131/016 (1 bočica s praškom, 1 ampula s otapalom) EU/1/00/131/017 (1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje)
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici PegIntron 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici PegIntron 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici PegIntron 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici peginterferon alfa-2b
EU/1/00/131/035 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/036 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/038 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/131/035 (1 brizgalica, 1 igla za injekciju i 2 tupfera za čišćenje) EU/1/00/131/036 (4 brizgalice, 4 igle za injekciju i 8 tupfera za čišćenje) EU/1/00/131/038 (12 brizgalica, 12 igala za injekciju i 24 tupfera za čišćenje)
EU/1/00/131/020 (6 vials of powder, 6 ampoules of solvent) EU/1/00/131/029 (12 vials of powder, 12 ampoules of solvent, 12 injection syringes, 24 injection needles and 12 cleansing swabs)
EU/1/00/131/020 (6 bočica s praškom, 6 ampula s otapalom) EU/1/00/131/029 (12 bočica s praškom, 12 ampula s otapalom, 12 štrcaljki za injekciju, 24 igle za injekciju i 12 tupfera za čišćenje)
EU/1/00/131/043 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/044 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/046 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/131/043 (1 brizgalica, 1 igla za injekciju i 2 tupfera za čišćenje) EU/1/00/131/044 (4 brizgalice, 4 igle za injekciju i 8 tupfera za čišćenje) EU/1/00/131/046 (12 brizgalica, 12 igala za injekciju i 24 tupfera za čišćenje)
EU/1/00/131/018 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/019 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
EU/1/00/131/018 (4 bočice s praškom, 4 ampule s otapalom) EU/1/00/131/019 (4 bočice s praškom, 4 ampule s otapalom, 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje)
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 50 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 50 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
EU/1/00/131/021 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/022 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/131/021 (1 bočica s praškom, 1 ampula s otapalom) EU/1/00/131/022 (1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje)
PegIntron 80 micrograms powder for injection peginterferon alfa-2b
PegIntron 80 mikrograma prašak za injekciju peginterferon alfa-2b s.c.
PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 80 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 80 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.